Home Markets U.S. FDA declines to approve Revance’s frown-line treatment U.S. FDA declines to approve Revance’s frown-line treatment Andrew M Oct 16, 2021 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/us-fda-declines-to-approve-revances-frownline-treatment-2645689 FDA Market Updates U.S. FDA www.investing.com/news/stock-market-news/us-fda-declines-to-approve-revances-frownline-treatment-2645689